1. Home
  2. Products
  3. Infectious Disease
  4. COVID-19 (SARS-CoV-2) IgG ELISA

COVID-19 (SARS-CoV-2) IgG ELISA

DECOV1901

Enzyme immunoassay for the qualitative determination of IgG class antibodies against COVID-19 (SARS-CoV-2) in human serum or plasma
MethodELISA
Tests96
Incubation Time / Conditions1 h (37°C), 30 min (RT), 15 min (RT/dark)
Standard RangeCut-off
Sensitivity analyticaldiagn. 100 % (>12 days)
Final Sample Volume100 µl
Sample Typeserum, plasma (citrate, heparin)
Sample Pretreatment1:101 diluted
Isotope / Substrate / ModeTMB 450 nm
kBq-
Internal Controls-
Regulatory StatusCE/RUO
Add to InfopackageCOVID-19 (SARS-CoV-2) IgG ELISA
  Downloads
Material Safety Data Sheet
For illustrative purposes only
PDF | 5 MB

 Instructions for Use
For illustrative purposes only
PDF | 698.6 KB

Related Products
COVID-19 (SARS-CoV-2) IgA ELISADECOV1902
Interleukin-6 human ELISADE4640
TNF-alpha human ELISADE4641
COVID-19 (SARS-CoV-2) quantitative IgG ELISADECOV1901Q
Product Categories
Allergy Autoimmunity Biogenic Amines Bone Metabolism Cardiovascular disease Diabetes Down-Syndrome Food Analytics Food Intolerance Growth Factor Hematology Immunology Infectious Disease LC-MS/MS Nephrology Reproduction Salivary Diagnostics Specialities Thyroid Thyroid Antibodies Tumormarker Veterinary Diagnostics